Seer (NasdaqGS:SEER) Q1 2026 Earnings call May 13, 2026 04:30 PM ET Company ParticipantsDavid Horn - CFO and PresidentMarissa Bych - Managing DirectorOmid Farokhzad - CEO and Chair of the BoardConference Call ParticipantsKyle Boucher - AnalystKyle Mikson - AnalystOperatorGood day, and welcome to Seer 1st quarter 2026 earnings conference call. I would now like to turn the conference over to Marissa Bish from Gilmartin Group. Please go ahead.Marissa BychThank you. Earlier today, Seer released financial result ...

David Horn - CFO and President Marissa Bych - Managing Director Omid Farokhzad - CEO and Chair of the Board Seer (NasdaqGS:SEER) Q1 2026 Earnings call May 13, 2026 04:30 PM ET Company Participants Conference Call Participants Kyle Boucher - Analyst Kyle Mikson - Analyst Operator Good day, and welcome to Seer First Quarter 2026 Earnings Conference Call. All participants will be in listen- only mode. Should you need assistance please signal the conference specialist or pressing the star key followed by zero. ...

业绩总结 - 2026年第一季度收入为280万美元，同比下降33.3%（2025年为420万美元）[20] - 产品和服务收入为260万美元，同比下降36.6%（2025年为410万美元）[20] - 毛利率为35%，较2025年的49%下降了14个百分点[20] - 运营费用为1820万美元，同比下降20.3%（2025年为2280万美元）[20] - 净亏损为1680万美元，较2025年的1990万美元有所改善[20] - 自由现金流为-1570万美元，较2025年的-1210万美元有所恶化[20] - 截至2026年3月31日，公司现金、现金等价物和投资总额约为2.2亿美元，无债务[20] 股票回购 - 第一季度回购约150万股股票，总回购股份达到1320万股，减少净流通普通股约15%[21] 未来展望 - 2026年全年收入指导为1600万至1800万美元，预计中位数同比增长约3%[22] - 2026年增长催化剂包括通过新产品创新扩大可寻址市场，推动快速扩张的已安装基础的利用率[23]

Seer defends its pioneering Proteograph® Product Suite intellectual property (IP) REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has filed a patent infringement suit against Nanomics Biotechnology Co., Ltd. The asserted patents, U.S. Patent Nos. 11,435,360, 11,630,112, 12,050,222, 12,228,566, and 12,590,948, protect Seer’s intellectual property in the field of nanoparticle protein ...